Chemoinformaics analysis of Cannabicoumaronic-Acid
Molecular Weight | 244.224 | nRot | 4 |
Heavy Atom Molecular Weight | 236.16 | nRig | 10 |
Exact Molecular Weight | 244.004 | nRing | 1 |
Solubility: LogS | -1.14 | nHRing | 0 |
Solubility: LogP | -0.099 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 28.0763 |
nHD | 2 | BPOL | 17.2857 |
QED | 0.604 |
Synth | 2.082 |
Natural Product Likeliness | 0.688 |
NR-PPAR-gamma | 0.012 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.788 |
CACO-2 | -5.473 |
MDCK | 0.0000123 |
BBB | 0.026 |
PPB | 0.990621 |
VDSS | 0.215 |
FU | 0.014265 |
CYP1A2-inh | 0.038 |
CYP1A2-sub | 0.061 |
CYP2c19-inh | 0.057 |
CYP2c19-sub | 0.048 |
CYP2c9-inh | 0.084 |
CYP2c9-sub | 0.743 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.12 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.022 |
CL | 1.15 |
T12 | 0.578 |
hERG | 0.012 |
Ames | 0.004 |
ROA | 0.478 |
SkinSen | 0.951 |
Carcinogencity | 0.057 |
EI | 0.976 |
Respiratory | 0.934 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.936491 |